Provided by Tiger Trade Technology Pte. Ltd.

Boise Cascade

74.15
-1.8200-2.40%
Post-market: 74.150.00000.00%19:30 EDT
Volume:421.36K
Turnover:31.45M
Market Cap:2.59B
PE:25.55
High:76.20
Open:76.20
Low:74.11
Close:75.97
52wk High:91.97
52wk Low:65.00
Shares:34.89M
Float Shares:34.34M
Volume Ratio:1.17
T/O Rate:1.23%
Dividend:0.88
Dividend Rate:1.19%
EPS(TTM):2.90
EPS(LYR):3.53
ROE:5.06%
ROA:2.86%
PB:1.28
PE(LYR):21.01

Loading ...

UK manufacturers facing ‘steel quota cliff edge’

cityam
·
Jun 17

Government should fix ‘stubbornly weak’ growth with policy test, industry body argues

cityam
·
Jun 15

Boise Cascade Company (NYSE:BCC) Pays A US$0.22 Dividend In Just Three Days

Simply Wall St.
·
May 28

A Look At Boise Cascade (BCC) Valuation After Recent Share Price Weakness

Simply Wall St.
·
May 27

Boise Cascade Reaffirmed at Buy on Strong Q1, Solid Outlook and Financial Flexibility; $105 Price Target Unchanged

TIPRANKS
·
May 15

Boise Cascade SVP, General Counsel Jill Twedt sells 6,070 shares for $403,352.11

Reuters
·
May 15

Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 15

Industry chief calls on government to water down steel tariff plans

cityam
·
May 14

Boise Cascade (BCC) Valuation Check After Q1 2026 Earnings Beat And Softer Results

Simply Wall St.
·
May 11

Boise Cascade price target lowered to $97 from $100 at Truist

TIPRANKS
·
May 07

Boise Cascade Is Maintained at Buy by DA Davidson

Dow Jones
·
May 07

Truist Adjusts Price Target on Boise Cascade to $97 From $100, Maintains Buy Rating

MT Newswires Live
·
May 06

Boise Cascade Co : Truist Securities Cuts Target Price to $97 From $100

THOMSON REUTERS
·
May 06

U.S. RESEARCH ROUNDUP-IBM, Lumentum Holdings, TransDigm Group

Reuters
·
May 06

Boise Cascade Earnings Call: Profits Squeezed, Payouts Hold

TIPRANKS
·
May 06

Analysts Offer Insights on Materials Companies: Chemours Company (CC) and Boise Cascade (BCC)

TIPRANKS
·
May 06

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting

GlobeNewswire
·
May 06

Boise Cascade Is Maintained at Buy by DA Davidson

Dow Jones
·
May 06

Boise Cascade publishes investor presentation on building materials distribution, engineered wood products strategy

Reuters
·
May 05

Boise Cascade Reports Lower First-Quarter 2026 Net Income

TIPRANKS
·
May 05